Clinical Trials Directory

Trials / Completed

CompletedNCT02563132

Carbon Dioxide Insufflation Colonoscopy in IBD Patients

Carbon Dioxide Insufflation Colonoscopy in Inflammatory Bowel Disease Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Vitkovice Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Carbon dioxide insufflation during colonoscopy significantly reduces discomfort (pain, bloating and flatulence) after the procedure. So far, it has not been studied in inflammatory bowel disease patients. The study was designed to evaluate discomfort after the carbon dioxide insufflation colonoscopy in comparison to standard air insufflation colonoscopy.

Detailed description

Carbon dioxide insufflation during colonoscopy significantly reduces discomfort (pain, bloating and flatulence) during up to 24 hours after the procedure. So far, it has not been studied in inflammatory bowel disease patients who represent specific patient population indicated for colonoscopy. They are characterized by younger age, structural changes of the colon including intestinal resections and need for repeated and frequently difficult procedures.The study was designed to evaluate discomfort during 24 hours after the carbon dioxide insufflation colonoscopy in comparison to standard air insufflation colonoscopy.

Conditions

Interventions

TypeNameDescription
PROCEDURECarbon dioxide insufflationCarbon dioxide insufflation during diagnostic colonoscopy

Timeline

Start date
2015-10-01
Primary completion
2016-05-01
Completion
2016-05-01
First posted
2015-09-29
Last updated
2016-06-01

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT02563132. Inclusion in this directory is not an endorsement.